480P CATRIPCA – A phase I of pembrolizumab (P) combined with Xevinapant (Debio 1143, (X)) in patients (pts) with non MSI-high advanced/metastatic pancreatic ductal adenocarcinoma (PDAC) or colorectal cancer (CRC)

Authors :: P.A. Cassier
C. Terret
A. Voisin
C. Schiffler
A-S. Bidaux
H. Vanacker
L. Eberst
M.W. Lepercq
A. D'Argenio
null M. Bernardin
A. Bouhamama
L. Gilles-Afchain
I. Treilleux
S. Tabone-Eglinger
D. Spaggiari
S. Chabaud
Y. Grinberg-Bleyer
G. Garin
D. Perol
A. Vinceneux
Source :: Annals of Oncology. 33:S759
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools